Choose your location

Latest
Artemis-II astronauts saw mysterious island of light on the Moon as they flew close $1,000,000,000,000: Cost of serving the debt storm in developing countries INDIA Bloc Protest Live: Fresh FIR against Rahul Gandhi, Priyanka over alleged assault, obstruction during stir Northern Ireland Assembly - Urgent Question on the First Minister on BBC Parliament: full details and when it's on Spanish pensioner whose eviction sparked nationwide protests dies, union says The road to self-driving laboratories in industry

The road to self-driving laboratories in industry

In this issue, we focus on the development of self-driving laboratories for the autonomous synthesis of molecules and materials, with a particular focus on industrial considerations and applications.

Nature

In this issue, we focus on the development of self-driving laboratories for the autonomous synthesis of molecules and materials, with a particular focus on industrial considerations and applications. Self-driving laboratories, which combine robotics, automation and artificial intelligence (AI) to autonomously plan and run experiments, are being used to accelerate research.

Moving this technology from academic proof of concept to industrial practice, however, can be challenging. This issue of Nature Synthesis brings together researchers working on developing self-driving laboratories to autonomously explore chemical space and accelerate the synthesis of molecules and materials.

In particular, the viewpoint of industrial researchers working all over the world to advance this technology is highlighted, with input from researchers at: AbbVie, AstraZeneca, Bristol Myers Squibb, Center for the Transformation of Chemistry, China Energy Investment Corporation, Eli Lilly and Company, eN-RAMPS, Genentech, NVIDIA, Samsung Advanced Institute of Technology, Takeda Pharmaceutical Company, and Zoetis.

Credit: onurdongel / Getty Images A Perspective by Meenesh Singh and co-workers brings together industrial researchers from companies working on biopharmaceutical research and discusses the use of self-driving laboratories for biopharmaceutical discovery and development. Recent industrial applications in solubility screening, solid-form characterization, electrochemical synthesis and lipid nanoparticle formulation are discussed, with an eye towards a future in which continuously learning, data-driven laboratories become foundational infrastructure for improving reproducibility across the biopharmaceutical industry as well as accelerating drug discovery and development.

Related to this goal, a Research Highlight in this issue based on work by Youxiang Wang, Qiao Jin and co-workers describes an active-learning platform, termed PolyCAML, that couples automated synthesis, high-throughput characterization, and machine learning to accelerate the discovery of antifungal, peptide-mimicking copolymers.

On the topic of using self-driving laboratories for discovery, recent work published in Nature Synthesis from researchers in academia describes some of the advances in robotics and AI for reaction screening which hold promise for discovering new reactions and making self-driving laboratories more affordable and accessible.

For example, an Article by Bartosz Grzybowski and co-workers reports the discovery of a pseudo-seven-component transformation based on the century-old Biginelli reaction by using a robotic platform to examine chemical reactivity across multidimensional ‘hyperspaces’ of conditions.

Continue reading

Watch a short ad to unlock the full article

The rest stays locked if you skip or close the ad early.

Article text via FreeNewsAPI. Rights remain with Nature.

Read on publisher site → Opens Nature in a new tab

More in Local